You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Development of a Dynamic SCA 4.1 Waveform Compliance Test Platform

    SBC: RESERVOIR LABS INC            Topic: AF06067

    The Software Communications Architecture (SCA) 4.1 is emerging as the worldwide standard for tactical software-defined radio waveform development. The lack of automated test tools targeted to the SCA is a limiting factor in the certification cycle, resulting in longer turnaround times at JTEL, which, in turn, jeopardizes the timely introduction of required waveforms and upgrades. Due to the scope ...

    SBIR Phase II 2020 Department of DefenseNavy
  2. KeraStat(R) Burn Gel and Halofuginone to Prevent Scar Contracture after Burn Injuries

    SBC: Keranetics, LLC            Topic: DHP12016

    No currently available burn product has shown efficacy in substantially decreasing wound healing time and preventing scar formation. The goals of this Phase II proposal are to expand on the results obtained in the Phase I study that showed that (1) halofuginone inhibited collagen-mediated contracture in dermal fibroblasts and (2) the presence of the keratin in the KeraStat burn product results in ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  3. Development and Commercialization of a Tau Oligomer Inhibitor for AD/RD

    SBC: Oligomerix, Inc.            Topic: NIA

    TITLE: Development and Commercialization of a Tau Oligomer Inhibitor for AD/RD PROJECT SUMMARY - SBIR/STTR Commercialization Readiness Pilot (CRP) Program (PAR-19-333) The long-term goal of this program is to develop a disease-modifying, small molecule drug for Alzheimer’s disease (AD) and related dementias (ADRD). There is a critical unmet need for a disease modifying drug for AD. Chronic treat ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  4. Long-lasting Disposable Insecticidal / Repellent Fabric Barrier for Personal or Area Protection Against Biting Arthropods

    SBC: Widder Bros., Inc.            Topic: DHP13003

    The Phase II Technical Objectives align with the project goals of developing an outdoor device for spatial protection in a defined, limited outdoor area. While existing work has proven out technology which is effective in indoor areas, the work has not b

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  5. Cartilage Regeneration with Tunable Inflammation Resistance

    SBC: Cytex Therapeutics, Inc.            Topic: R

    Abstract: Femoroacetabular impingement or FAI is a commonly diagnosed condition affecting a younger patient population than the general osteoarthritis (OA) population. Untreated, FAI invariably leads to OA and, ultimately, total hip arthroplasty (THA). The fact that most FAI diagnoses are made in patients under the age of 40, with many in their late teens and twenties, makes FAI all the more clini ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  6. Devices to Prevent and Treat Retained Hemothorax after Chest Injury

    SBC: Sim Vivo            Topic: DHP16011

    Blood in thechestcavity (hemothorax) as a result of injury remains a common and seriouschallengein military and civilian trauma management. The primary treatment of hemothoraxrequires a tubeto beinserted into the pleural space around thelung. Unfortunately, in about20% of thecases,significant amounts of blood,clot, and fibrin remain after initial drainage.Left untreated, thiscan lead to a permanen ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  7. Iron.Scan – a multiplexed point-of-care diagnostic system for diagnosing anemia and iron deficiency

    SBC: VITAME TECHNOLOGIES INC            Topic: DHP16005

    VitaMe Technologies Inc. (doing business as “VitaScan”) and Cornell University will develop the “Iron.Scan” - a point-of-care system for iron deficiency and anemia diagnosis in about 10 minutes from a finger stick of blood. The system comprises of (1) an

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  8. Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection

    SBC: Baebies, Inc.            Topic: NHLBI

    ABSTRACTImproving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low VolumeBlood Samples Obtained by Heel-Stick Collection Children treated for congenital heart defects or other disorders of hypercoagulation are prescribed unfractionated heparin (UFH) or low molecular weight heparin (LMWH) throughout surgical treatment; they may be prescribed heparin for u ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  9. Rapid field testing of field water samples for total coliform and E. coli using isothermal amplification and unique micron-sized particles for cell capture and concentration

    SBC: IFYBER, LLC            Topic: DHA17004

    iFyberLLC proposes to develop acoliform assay with differential detection of E.coliand total coliform that will circumvent thecurrent challenges with detectingthese organismsatalevel of1 CFU per100mLin less than 8 hours. The proposed assay targetsaresult in less than 8 hours by making use of novel microspherereagents forcaptureand concentration of thetargetcells,and couplingthesereagents with loop ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  10. Sentient Science- A Multiscale Modeling Suite for Process and Microstructure Prediction in Metal Additive Manufacturing

    SBC: Sentient Science Corporation            Topic: T12

    In the Phase I period, Sentient upgraded its DigitalClone for Additive Manufacturing (AM) technology and successfully demonstrated and validated its ldquo;Process modelrdquo; and ldquo;Microstructure modelrdquo; for simulating metal AM processes. Sentient has partnered with University of Nebraska ndash; Lincoln for model validation.Specifically, Sentient has implemented a new ldquo;Process modelrd ...

    STTR Phase II 2020 National Aeronautics and Space Administration
US Flag An Official Website of the United States Government